Skip to Content

GSI 250 (Viread 250 mg)

Generic Name: tenofovir

Pill with imprint GSI 250 is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc..

Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 250

Viread 250 mg GSI 250

Viread

Generic Name:
tenofovir
Imprint:
GSI 250
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
Inactive Ingredients:
corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide